Reports

• Publish Date: May-2022
• Report Code: QI042
• Price: $ 1800/-

Europe after North America is the second largest market leading the cancer screening market. The market is forecasted to grow at a compound annual growth rate of (CAGR) of 8.1% resulting in an annual revenue of USD 22.43 Bn during the forecast period (2018-2023). Increase in the aging population along...

• Publish Date: May-2022
• Report Code: QI042
• Price: $ 1800/-

The Latin America cancer screening market is currently valued at USD 21.24 billion and is forecasted to achieve a growth rate of 7.19 % compound annual growth rate (CAGR) leading to a regional revenue of USD 30.06 Bn. Latin Americas growth is much slower compared to other regions. The region...

• Publish Date: May-2022
• Report Code: QI042
• Price: $ 1800/-

The Middle East and Africa (MEA) cancer screening market is growing at a very slow rate. The MEA market is projected to reach USD 50.61 Bn by 2023, at a compound annual growth rate (CAGR) of 11.5% during the forecast period (2018-2023).The United Arab Emirates (UAE), Saudi Arabia and Kuwait...

• Publish Date: May-2022
• Report Code: QI042
• Price: $ 1800/-

North America is leading the cancer screening market. The region is technologically equipped and being a developed economy it is efficiently catering to the rising incidence of cancer cases. The market is forecasted to grow at a compound annual growth rate (CAGR) f 11.14% resulting in an annual revenue of...